Keymed Biosciences Co.ltd

This study tests a new drug called CM336 against standard treatments for people with multiple myeloma whose cancer has returned or stopped responding after at least two prior therapies. About 280 adults will be randomly assigned to receive either CM336 or a standard treatment cho…

This study tests a new drug called CM313 in 106 adults with IgA nephropathy, a kidney disease. The goal is to see if the drug is safe and helps control the disease. Participants must have had a kidney biopsy showing IgA nephropathy within the last 8 years and be on standard care.…

This study tests the safety and effectiveness of a drug called CM512 in 120 people with chronic sinusitis and nasal polyps. Participants must have been in a previous CM512 study. The goal is to see if CM512 can help control the disease, but ongoing treatment may be needed.